Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 9, 2021
Clovis Oncology Highlights FAP-2286 Preclinical Data Presented at the Targeted Radiopharmaceuticals Summit Download PDF format download (opens in new window)
November 3, 2021
Clovis Oncology Announces Third Quarter 2021 Operating Results Download PDF format download (opens in new window)
October 20, 2021
Clovis Oncology to Announce Third Quarter 2021 Financial Results and Host Webcast Conference Call on November 3 Download PDF format download (opens in new window)
October 19, 2021
Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement Download PDF format download (opens in new window)
October 7, 2021
Pan-Cancer Analysis Suggests Fibroblast Activation Protein (FAP) is an Attractive Target for Peptide-Targeted Radionuclide Therapy with FAP-2286 Download PDF format download (opens in new window)
September 20, 2021
Clovis Oncology Retires Remaining 2021 Notes and Raises Additional Capital through its ATM Equity Offering Program Download PDF format download (opens in new window)
August 16, 2021
Clovis Oncology Announces Renewal of At-The-Market Equity Offering Program Download PDF format download (opens in new window)
August 4, 2021
Clovis Oncology Announces Second Quarter 2021 Operating Results Download PDF format download (opens in new window)
July 21, 2021
Clovis Oncology to Announce Second Quarter 2021 Financial Results and Host Webcast Conference Call on August 4 Download PDF format download (opens in new window)
July 12, 2021
Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors Download PDF format download (opens in new window)
June 28, 2021
Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine Download PDF format download (opens in new window)
June 23, 2021
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for Enrollment Download PDF format download (opens in new window)
June 10, 2021
Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders Download PDF format download (opens in new window)
May 19, 2021
Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual Meeting Download PDF format download (opens in new window)
May 17, 2021
Clovis Oncology Announces At-The-Market Equity Offering Program Download PDF format download (opens in new window)
May 5, 2021
Clovis Oncology Announces First Quarter 2021 Operating Results Download PDF format download (opens in new window)
April 28, 2021
Clovis Oncology to Present at the Bank of America 2021 Health Care Conference Download PDF format download (opens in new window)
April 21, 2021
Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5 Download PDF format download (opens in new window)
April 10, 2021
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021 Download PDF format download (opens in new window)
March 19, 2021
Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation Download PDF format download (opens in new window)
February 23, 2021
Clovis Oncology Announces 2020 Operating Results Download PDF format download (opens in new window)
February 17, 2021
Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23 Download PDF format download (opens in new window)
February 11, 2021
Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting Download PDF format download (opens in new window)
February 4, 2021
Clovis Oncology to Highlight Data at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting Download PDF format download (opens in new window)
January 11, 2021
Clovis Oncology Announces Preliminary Product Revenues for the Fourth Quarter and Full Year 2020 Download PDF format download (opens in new window)